AbbVie and Teneobio Link on Multiple Myeloma

14.02.2019 - US biopharma AbbVie has agreed a deal with Teneobio, a California-based biotech, to develop and commercialize an immunotherapeutic that targets B-cell maturation antigen (BCMA) for...